NASA’s Jet Propulsion Laboratory in Southern California has selected eight U.S. manufacturers to make a new ventilator for COVID-19 patients from a pool of more than 100 applicants.

The prototype, which was created by JPL engineers in just 37 days, received an Emergency Use Authorization from the Food and Drug Administration on April 30.

Called VITAL (Ventilator Intervention Technology Accessible Locally), the high-pressure ventilator was designed to use one-seventh the parts of a traditional ventilator, relying on parts already available in supply chains. It offers a simpler, more affordable option for treating critical patients while freeing up traditional ventilators for those with the most severe COVID-19 symptoms. Its flexible design means it also can be modified for use in field hospitals.

Read the full article on SciTechDaily.